Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAU pseudogene 1 (FAUP1) is a processed pseudogene derived from the FAU gene, which encodes a ribosomal protein S30 fused with a ubiquitin-like domain. FAUP1 is transcriptionally silent, contains an intact but not expressed open reading frame of 137 codons, and is located on chromosome 18. It exists in an antisense orientation relative to a sequence homologous to the promoter of the islet amyloid polypeptide (amylin) gene. There is no evidence supporting that FAUP1 encodes a functional protein or has a recognized role as a therapeutic or diagnostic target. FAUP1 is not a gene product (e.g., receptor, enzyme, transporter), but rather a non-functional genomic remnant. The canonical, functional gene is FAU, not FAUP1. No associated drugs, mechanisms, or disease roles are described in the biomedical literature for this pseudogene. The gene is included in gene databases as a pseudogene with no known protein product or function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAU pseudogene 1 (FAUP1).